https://qilindo.com/wp-content/uploads/2021/07/Viritis-with-intro.mp4

Viritis

Cure Viral Diseases

Play Video
Play Video

Video

Presentation

One Pager

Favorites

Raising

$300,000

in exchange for

30%

Industry

Health & Wellness

Company Size

2-5

Patent

No

Location

Israel

Languages

English, Hebrew

Viral diseases cause millions of deaths each year. Although vaccines are a viable solution, they are far from perfect. The process of creating a vaccine is lengthy, expensive, and difficult because each virus requires a specific vaccine and random mutations can harm the vaccine’s effectiveness.

We are developing an antiviral drug that can destroy the target virus at the cellular level without causing harm to the cell or the body.

In addition to our drug, we are changing the way modern medicine combats viral pandemics, from preventive to active treatment.

The Vision

To cure the world of viral diseases

The Product

We at Viritis have developed a new antiviral drug that can destroy pathogenic viruses at the cellular level without harming the cell itself.

Our product is an antiviral drug including our hybrid molecule and nanotechnology delivery mechanism. The molecule and therapeutic method are patentable to our knowledge.

Overview

Viral diseases cause millions of deaths each year. Although vaccines are a viable solution, they are far from perfect. The process of creating a vaccine is lengthy, expensive, and difficult because each virus requires a specific vaccine and random mutations can harm the vaccine’s effectiveness.

We are developing an antiviral drug that can destroy the target virus at the cellular level without causing harm to the cell or the body.

In addition to our drug, we are changing the way modern medicine combats viral pandemics, from preventive to active treatment.

The Vision

To cure the world of viral diseases

The Product

We at Viritis have developed a new antiviral drug that can destroy pathogenic viruses at the cellular level without harming the cell itself.

Our product is an antiviral drug including our hybrid molecule and nanotechnology delivery mechanism. The molecule and therapeutic method are patentable to our knowledge.

The Team

Please Sign In or Register to view this content.

The Market

Please Sign In or Register to view this content.

Problem & Solution

Pathogenic viruses are considered a major threat to world population health. The existing solution for viral diseases is antiviral drugs and vaccines, both limited in their therapeutic effects.

We at Viritis Ltd. developed a new anti-viral drug and delivering mechanism that has the ability to fight and hinder pathogenic viruses at the cellular level.

Attributes:

  • Strong affinity for viruses and only viruses
  • Reduces symptoms from the first use
  • Virtually no side effects
  • One drug may be used to treat several viruses
  • No lasting damage to the cell

Please Sign In or Register to view this content.

A D D M Y S T A R T U P

Get Full Access

We need to know you better

Before we approve and open the option to send messages to all the startups, we need to know you better. please fill out the form:

Want to See More?

Sign up as an investor or add your startup to gain full access.
It’s absolutely free!

Don't Miss An Opportunity

Sign up as a investor and gain full access. It’s absolutely free!

New Report

Close